cancerpatients
-
Conferences
ESMO’22 Recommended Abstracts in RENAL CANCERS
Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. These recommended abstracts from ESMO 2022 Annual meeting have been…
Read More » -
Cancer
Gene activity Can Provide Clues for Risk of Kidney Cancer Spreading
OCTOBER 17, 2022 – 4 MINUTES READ The activity of four specific genes in the cancer cells seems to…
Read More » -
Cancer
A 20-year retrospective: How Kidney Cancer Journal Reflected on Advances in The Therapeutic Strategies
Robert A Figlin, MD, FACP1 , Senthil Pazhanisamy, PhD2 1. Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles…
Read More » -
Conferences
2022 ESMO: Promise and Pitfalls of Adjuvant Immunotherapy
ESMO’22 Special Robert A. Figlin, MD, FACS Cedars Cinai Cancer Center, Los Angeles, CA Correspondence: RAF There was never a…
Read More » -
Kidney Cancer
Optimal Duration of Therapy in Metastatic RCC: Exploring Treatment-Free Survival with Checkpoint Inhibitors
Grayce N. Selig, MD1 Christopher J. Hoimes, DO,2 Joe Bible, PhD,3 Daniel J. George, MD,2 Michael R. Harrison, MD2 1. Duke University Medical Center…
Read More » -
ASCO
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting
. Updated Yasser Ged,1 and Nirmish Singla2,* 1) Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA…
Read More » -
Cancer
Engineered T-Cell Therapy: The Next Direction for RCC Immuno-oncology?
JJ H. Zhang, MD,1 Neal A. Patel, MD,1 Alexandra Drakaki, MD, PhD,1,2 Allan J. Pantuck, MD1,* 1) Institute of Urologic Oncology, Department of…
Read More » -
Kidney Cancer
Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2: A Secondary Data Analysis
Melissa Paquin, PhD,1 Tracy Fasolino, PhD, FNP,2 Joe Bible, PhD,3 Mary Beth Steck, PhD,2 Joel Williams, PhD.4 1. Clemson University, Hampton, GA 30228 USA.…
Read More » -
GU CANCERS
Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in Renal Cell Carcinoma
Robert J Motzer, MD 1, Toni K Choueiri, MD 2, Laurence Albiges, MD, PhD 3,Robert A. Figlin, MD, FACP4 Memorial…
Read More » -
Kidney Cancer
From Gene Discovery to a FDA approval; Belzutifan’s Fascinating Journey at UTSW
Published on: August 21, 2021 A novel kidney cancer drug developed from UT Southwestern Medical Center received approval from the Food…
Read More »
